Nanion Corporate Blog


01.02.2019: New Application Note showing P2X2/3 recorded on the SyncroPatch 384PE with 97% success rates now available!

We have recorded P2X2/3 expressed in CHO cells from Axxam S.p.A., Milan on the SyncroPatch 384PE with success rates of over 97% for completed, full concentration response curves on each well. Cells were stable for 45 minutes on the SyncroPatch 384PE and P2X2/3 could be repetitively and reproducibly activated, control peak amplitudes varied by just 5%. Find your next pain therapeutic using the SyncroPatch 384PE!

Download the Application Note here


Back to Overview

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok